Alaska Permanent Fund Corp Buys 4,147 Shares of Amdocs Limited (NASDAQ:DOX)

Alaska Permanent Fund Corp increased its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 2.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 147,561 shares of the technology company’s stock after acquiring an additional 4,147 shares during the quarter. Alaska Permanent Fund Corp owned about 0.13% of Amdocs worth $12,969,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. GAMMA Investing LLC acquired a new stake in Amdocs during the 4th quarter worth approximately $25,000. Marks Group Wealth Management Inc lifted its position in shares of Amdocs by 1.2% in the 4th quarter. Marks Group Wealth Management Inc now owns 75,075 shares of the technology company’s stock worth $6,598,000 after purchasing an additional 915 shares during the period. Illinois Municipal Retirement Fund increased its stake in shares of Amdocs by 4.2% in the 4th quarter. Illinois Municipal Retirement Fund now owns 123,278 shares of the technology company’s stock valued at $10,835,000 after acquiring an additional 4,982 shares in the last quarter. New York State Common Retirement Fund increased its stake in shares of Amdocs by 6.1% in the 4th quarter. New York State Common Retirement Fund now owns 574,155 shares of the technology company’s stock valued at $50,462,000 after acquiring an additional 32,921 shares in the last quarter. Finally, Wedge Capital Management L L P NC increased its stake in shares of Amdocs by 9.3% in the 4th quarter. Wedge Capital Management L L P NC now owns 917,808 shares of the technology company’s stock valued at $80,666,000 after acquiring an additional 77,833 shares in the last quarter. 92.02% of the stock is owned by institutional investors.

Amdocs Trading Down 1.2 %

Shares of Amdocs stock traded down $1.00 on Thursday, hitting $85.74. The stock had a trading volume of 13,565 shares, compared to its average volume of 643,612. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.21. Amdocs Limited has a one year low of $78.38 and a one year high of $99.75. The stock has a market cap of $10.08 billion, a price-to-earnings ratio of 18.57, a PEG ratio of 1.41 and a beta of 0.69. The stock’s 50-day simple moving average is $89.86 and its two-hundred day simple moving average is $87.32.

Amdocs (NASDAQ:DOX) last announced its earnings results on Tuesday, February 6th. The technology company reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.16. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The firm had revenue of $1.25 billion for the quarter, compared to analysts’ expectations of $1.24 billion. During the same quarter in the previous year, the business posted $1.33 EPS. The company’s quarterly revenue was up 5.0% on a year-over-year basis. As a group, sell-side analysts predict that Amdocs Limited will post 5.87 EPS for the current year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be given a $0.479 dividend. This represents a $1.92 annualized dividend and a dividend yield of 2.23%. The ex-dividend date of this dividend is Wednesday, March 27th. This is a positive change from Amdocs’s previous quarterly dividend of $0.44. Amdocs’s payout ratio is currently 41.11%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on DOX. Barclays boosted their price target on shares of Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a research note on Thursday, February 8th. Citigroup boosted their price target on shares of Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Finally, StockNews.com downgraded shares of Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, March 15th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, Amdocs currently has a consensus rating of “Buy” and a consensus price target of $108.60.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.